BioSerenTach Inc.
About
BioSerenTach started in 2001 when Prof. Takada was at Kyoto Pharmaceutical University to accelerate his DDS innovations, (1) oral DDS; gastrointestinal mucoadhesive patch system (GI-MAPS) and (2) percutaneous DDS; dissolving micropiles (DM). Our mission is to codevelop an new DDS preparations with pharmaceutical companies having drug candidates suffering from low bioavailability problem, especially middle molecule drug.
Business Domain / 分野
Business Type / 業種
Disease Area / 疾患領域
Modalities / モダリティ
Technologies / 技術
Additional questions
Researched company/organisation type / マッチングご希望企業・機関のタイプ
Researched disease area / マッチングご希望の疾患領域
Researched Modality / マッチングご希望のモダリティ
Researched Technologies / マッチングご希望の技術